Breaking News, Collaborations & Alliances

BostonGene, Kyoto University Enter Research Collaboration

Aim to refine and advance precision treatment strategies for esophageal squamous cell carcinoma patients.

Author Image

By: Charlie Sternberg

Associate Editor

BostonGene, the developer of an AI foundation model for cancer and the immune system, and Kyoto University, a research institution, have entered a research collaboration to develop advanced biological signatures to enhance targeted treatment strategies for patients with esophageal squamous cell carcinoma (ESCC). This research will leverage BostonGene’s AI-powered, multi-scale, omnimodal platform to analyze tumor molecular profiles and assess their correlation with response to a novel immune c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters